Document is current
Any future updates will be listed below
-
Authors
Dakhil, Shams http://orcid.org/0000-0003-3549-4568
Thingstad, Pernille
Frihagen, Frede
Johnsen, Lars Gunnar
Lydersen, Stian
Skovlund, Eva
Wyller, Torgeir Bruun
Sletvold, Olav
Saltvedt, Ingvild
Watne, Leiv Otto
-
Funding
Funding for this research was provided by:
Research Council of Norway
Norwegian National Health Association
Helse Sør-Øst RHF
Medical Student Research Program
Helse Midt-Norge
St. Olav Hospital Trust
Department of Neuromedicine and Movement science, NTNU
SINTEF
St. Olav Hospital Fund for Research and Innovation
Municipality of Trondheim
- License Information
-
More Information
Article History
Received: 3 September 2020
Accepted: 14 March 2021
First Online: 25 March 2021
Declarations
:
: The Oslo Orthogeriatric Trial was registered with ClinicalTrials.gov (NCT01009268), and approved by the Regional Committee for Ethics in Medical Research in South East of Norway (REK 2009/450). The Trondheim Hip Fracture Trial was registered with ClinicalTrials.gov (NCT00667914), and approved by the Regional Committee for Ethics in Medical Research in Central Norway (REK4.2008.335). The Regional Committee for Ethics in Medical Research in South East of Norway and the Data Protection Officer at both hospitals approved merging of data from the two separate trials.Both studies were conducted in accordance with the Declaration of Helsinki. The patients or a proxy gave informed written consent to be included in the study before participation in both trials.
: Not applicabale.
: I. Saltvedt has performed Alzheimer drug trial for Boehringer-Ingelheim 1346.0023. The remaining authors declare that they have no competing interests.
